- Home
- ALTG vs XFOR Comparison
ALTG vs XFOR Comparison
Compare ALTG & XFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTG
- XFOR
- Stock Information
- Founded
- ALTG 1984
- XFOR 2014
- Country
- ALTG United States
- XFOR United States
- Employees
- ALTG N/A
- XFOR N/A
- Industry
- ALTG Industrial Machinery/Components
- XFOR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALTG Industrials
- XFOR Health Care
- Exchange
- ALTG Nasdaq
- XFOR Nasdaq
- Market Cap
- ALTG 119.3M
- XFOR 118.4M
- IPO Year
- ALTG N/A
- XFOR N/A
- Fundamental
- Price
- ALTG $4.75
- XFOR $3.40
- Analyst Decision
- ALTG Buy
- XFOR Strong Buy
- Analyst Count
- ALTG 3
- XFOR 3
- Target Price
- ALTG $11.67
- XFOR $72.33
- AVG Volume (30 Days)
- ALTG 162.3K
- XFOR 180.2K
- Earning Date
- ALTG 05-07-2025
- XFOR 05-01-2025
- Dividend Yield
- ALTG 4.80%
- XFOR N/A
- EPS Growth
- ALTG N/A
- XFOR N/A
- EPS
- ALTG N/A
- XFOR 2.16
- Revenue
- ALTG $1,858,000,000.00
- XFOR $31,364,000.00
- Revenue This Year
- ALTG $2.05
- XFOR $915.88
- Revenue Next Year
- ALTG $3.24
- XFOR N/A
- P/E Ratio
- ALTG N/A
- XFOR $1.57
- Revenue Growth
- ALTG N/A
- XFOR N/A
- 52 Week Low
- ALTG $3.54
- XFOR $2.67
- 52 Week High
- ALTG $11.39
- XFOR $33.90
- Technical
- Relative Strength Index (RSI)
- ALTG 47.44
- XFOR 39.83
- Support Level
- ALTG $4.74
- XFOR $2.67
- Resistance Level
- ALTG $5.12
- XFOR $3.56
- Average True Range (ATR)
- ALTG 0.27
- XFOR 0.28
- MACD
- ALTG -0.04
- XFOR 0.21
- Stochastic Oscillator
- ALTG 2.15
- XFOR 82.02
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.